Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia

Nat Commun. Volume 6 p:6604, 19 March 2015, 10.1038/ncomms7604

There is incomplete understanding of genetic heterogeneity and clonal evolution during cancer progression. Here we use deep whole-exome sequencing to describe the clonal architecture and evolution of 20 pediatric B-acute lymphoblastic leukaemias from diagnosis to relapse. We show that clonal diversity is comparable at diagnosis and relapse and clonal survival from diagnosis to relapse is not associated with mutation burden. Six pathways were frequently mutated, with NT5C2, CREBBP, WHSC1, TP53, USH2A, NRAS and IKZF1 mutations enriched at relapse. Half of the leukaemias had multiple subclonal mutations in a pathway or gene at diagnosis, but mostly with only one, usually minor clone, surviving therapy to acquire additional mutations and become the relapse founder clone. Relapse-specific mutations in NT5C2 were found in nine cases, with mutations in four cases being in descendants of the relapse founder clone. These results provide important insights into the genetic basis of treatment failure in ALL and have implications for the early detection of mutations driving relapse.

In order to access Controlled TARGET ALL data using the links below, users must submit an application for Authorized Access via dbGaP as described on dbGaP’s TARGET Study Page. To begin the application process, please view the information and instructions provided on the dbGaP Authorized Access Login Page under “dbGaP Data Download”.

Supplemental Data Files

• GDC Manifests
  • Controlled-Access Data Download Manifest (6 Files)
  • Open-Access Data Download Manifest (22 Files)
  • WGS CGI Files Download Manifest (305 Files)

• Copy Number
  • TARGET ALL P2 Copy Number Array Level 1 Data (Controlled)
  • TARGET ALL P2 Copy Number Array Level 2 Data (Controlled)
  • TARGET ALL P2 Copy Number Array Level 3 Data
  • TARGET ALL P2 Copy Number Array Metadata
• Gene Expression Array
  • TARGET ALL P2 Gene Expression Array Level 1 Data
  • TARGET ALL P2 Gene Expression Array Level 2 Data
  • TARGET ALL P2 Gene Expression Array Level 3 Data
  • TARGET ALL P2 Gene Expression Array Metadata
• Methylation Array
  • TARGET ALL P2 Methylation Array Level 1 Data
  • TARGET ALL P2 Methylation Array Level 1 Data (Controlled)
  • TARGET ALL P2 Methylation Array Level 2 Data
  • TARGET ALL P2 Methylation Array Level 3 Data
  • TARGET ALL P2 Methylation Array Design Information
  • TARGET ALL P2 Methylation Array Metadata
• mRNA-Seq
  • TARGET ALL P2 mRNA-Seq Level 3 Data
  • TARGET ALL P2 mRNA-Seq Level 3 Data (Controlled)
  • TARGET ALL P2 mRNA-Seq Metadata
• miRNA-Seq
  • TARGET ALL P2 miRNA-Seq Level 3 Data
  • TARGET ALL P2 miRNA-Seq Metadata
• WGS
  • TARGET ALL P1 and P2 WGS L3 Data
  • TARGET ALL P1 and P2 WGS L3 Data (Controlled)
  • TARGET ALL P1 and P2 WGS L4 Data
  • TARGET ALL P2 and P2 WGS Metadata
• WXS
  • TARGET ALL P2 WXS Level 3 Data
  • TARGET ALL P2 WXS Level 3 Data (Controlled)
  • TARGET ALL P2 WXS Design Information
  • TARGET ALL P2 WXS Metadata
• Miscellaneous Files
  • TARGET ALL P2 Sample Matrix

Additional Resources

• TARGET-ALL-P2 at SRA (link is external) NCBI

Instructions for Data Download

Open Access Data

1. Download the appropriate manifest file from the publication page
2. Use the manifest file to download data using the GDC Data Transfer Tool (DTT) or the GDC API
   • GDC DTT (Download, User's Guide)
   • GDC API (User’s Guide)

Controlled Access Data

1. Download the appropriate manifest file from the publication page
2. Download a token from the GDC Data Portal
   • GDC Data Portal (Launch, User’s Guide)
3. Use the manifest file and token to download data using the GDC DTT or the GDC API
   • GDC DTT (Download, User’s Guide)
   • GDC API (User’s Guide)

For assistance, please contact the GDC Help Desk: support@nci-gdc.datacommons.io.